Business Context and Reporting Period
This Form 8-K Current Report was filed by Disc Medicine, Inc. on October 23, 2023. The filing addresses a material corporate governance event regarding the departure of a senior executive officer.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Executive Departure: Joanne Bryce, Chief Financial Officer (CFO), plans to depart from her position effective upon the identification of her successor.
- Reason for Departure: The departure is not the result of any disagreement with the Company's operations, policies, or practices.
- Interim Arrangements: Ms. Bryce will continue to serve as the Company's principal financial officer and principal accounting officer until a permanent successor is identified and hired.
- Succession Plan: The Company has commenced a formal search for Ms. Bryce's replacement.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, forward-looking outlook statements, or new risk factors beyond the standard disclosure of the executive transition. The Company indicated that the transition is being managed to ensure continuity of financial operations.
Key Facts for Investor Verification
- Verify the timeline for the appointment of the new Chief Financial Officer.
- Confirm that Ms. Bryce remains the principal financial and accounting officer during the interim period.
- Review the accompanying press release (Exhibit 99.1) for additional context on the transition.
- Monitor future filings for the announcement of the new CFO and any changes to the Company's financial reporting structure.